orphan designation

Related by string. Orphan designation * orphaned . Orphans . Orphaned . orphans . Orphan : Little Orphan Annie . widows orphans . Orphan Drug Designation . Swedish Orphan Biovitrum . Malawi orphans / Designations . designations . Designation . DESIGNATION : Fast Track designation . enemy combatant designation . Orphan Drug designation . wilderness designation * granted Orphan Designation *

Related by context. All words. (Click for frequent words.) 81 Orphan Drug designation 80 Orphan Drug Designation 79 Orphan Medicinal Product 78 orphan medicinal product 78 Orphan Designation 77 Orphan Drug status 77 Orphan designation 77 orphan drug 75 Orphan Status 73 Orphan Drug Status 72 Firazyr 71 OMP designation 71 Marketing Authorization 71 Orphan Drug designations 71 Orphan Drug 71 Fast Track Designation 71 Raptiva R 71 TEMODAL 71 Marketing Authorisation 70 Fast Track Status 70 FDA Orphan Drug 70 Fast Track designation 70 Preotact 70 Trobalt 70 Marketing Authorisation Application 69 CHMP recommendation 69 Lambert Eaton Myasthenic 69 Fast Track designations 68 Marketing Authorization Application 68 Mimpara 68 Application MAA 68 Certican 68 Torisel 68 SEBIVO 68 Granted Orphan Drug 68 Positive Opinion 67 Icatibant 67 Preotact R 67 Evoltra 67 Alvesco R 67 SNT MC# 67 Sanvar R 67 granted orphan medicinal 67 Evoltra ® 67 Syndrome LEMS 67 FIRAZYR 67 Yondelis ® 67 Romiplostim 67 Mepact 67 Octreolin 67 Noxafil 67 Cellegesic 66 Evoltra TM 66 ELIQUIS 66 Ceflatonin 66 Zenpep 66 XIAPEX ® 66 Kepivance 66 FRDA 66 Medicinal Products EMEA 66 Increlex R 66 Receives Marketing Authorization 66 Aviptadil 66 Accelerated Approval 66 MEPACT 66 Glybera R 66 histamine dihydrochloride 66 Centralized Procedure 66 Retacrit 66 Amrubicin 66 granted orphan 66 Revolade 66 Mutual Recognition Procedure 66 Pirfenidone 66 Alvesco ® 65 Arranon 65 Abstral 65 Thalidomide Pharmion 65 Esbriet ® 65 Vandetanib 65 Ixempra 65 Somatuline Depot 65 Actemra tocilizumab 65 Arzerra ofatumumab 65 CONBRIZA 65 rilonacept 65 ATryn ® 65 XIAPEX 65 Forsteo 65 Onconase 65 REBETOL combination therapy 65 Nexavar ® 65 Civacir 65 MAA submission 65 Febuxostat 65 SYCREST 65 Marketing Authorization Applications 65 RoACTEMRA 65 Tostrex 65 Orphan Drugs 65 Sebivo 65 AA amyloidosis 65 ACOMPLIA R 65 Cladribine 65 IRESSA 65 Angiox 65 Adenuric R 65 Receives Positive Opinion 65 Sycrest 65 Advagraf 65 SJIA 65 Zavesca 65 Ciclesonide 64 alvimopan 64 Orazol 64 Tarceva TM 64 FIRMAGON R 64 Dacogen injection 64 Gleevec Glivec 64 Cethrin 64 Uplyso 64 UPLYSO 64 GTC recombinant form 64 Zebinix R 64 hoFH 64 Peginterferon alfa 2b 64 ATryn R 64 Receives Orphan Drug Designation 64 Loramyc R 64 Loramyc ® 64 Friedreich Ataxia FRDA 64 severe gastroparesis 64 Marketing Authorization Application MAA 64 Plenaxis R 64 GTC recombinant human 64 Oracea ® 64 ACZ# 64 Ilaris 64 Nebido 64 OMAPRO ™ 64 Tyverb 64 Ruconest 64 Pfizer Sutent 64 Removab 64 Brilique 64 orphan medicinal 64 Fodosine 64 Onrigin 64 RoActemra 64 Raptiva ® 64 Loramyc 64 TORISEL 64 YONDELIS 64 Emezine 64 SUTENT ® 64 Priority Review 64 Bayer Onyx 64 Junovan 64 Nivestim 64 Etanercept 64 Zalbin 64 Nexavar tablets 64 PROMACTA 63 methylnaltrexone 63 rufinamide 63 Abstral ® 63 DORIBAX 63 Troxatyl TM 63 oropharyngeal candidiasis 63 CHMP opinion 63 Egrifta 63 Rhucin R 63 Alitretinoin 63 Cimzia ® certolizumab pegol 63 FDA Approvable Letter 63 Cladribine Tablets 63 Virulizin R 63 topical NSAID 63 Aryplase 63 Sutent sunitinib 63 Vernakalant 63 post menopausal osteoporosis 63 Teysuno 63 orBec 63 clofarabine 63 MAGE A3 ASCI 63 Orathecin 63 Xyrem ® 63 eltrombopag 63 Drug Eluting Stent System 63 Campath ® 63 Multiferon 63 Firdapse ™ amifampridine phosphate 63 Esbriet pirfenidone 63 thetreatment 63 Archexin 63 Rhucin ® 63 Dupuytren Contracture 63 Ranolazine 63 Aclasta 63 Zenvia ™ 63 histone deacetylase HDAC inhibitor 63 CryoSeal FS System 63 eprodisate KIACTA TM 63 Nexavar sorafenib 63 ELAPRASE 63 UCB Cimzia 63 Lenalidomide 63 Torisel temsirolimus 63 Cimzia TM 63 taliglucerase alfa 63 Evoltra R 63 Irinotecan 63 Nimotuzumab 63 Avastin bevacizumab 63 XGEVA 63 Angiox ® 63 Rapinyl 63 Advexin 63 Angiox R 63 Kit CD# positive 63 Argatroban 63 Combidex 63 registrational 63 Satraplatin 62 P#X# antagonist 62 BRILINTA 62 Silodosin 62 Hycamtin 62 Somatuline R Autogel R 62 vinflunine 62 briakinumab 62 Clevudine 62 Arcalyst 62 MPS VI 62 mifamurtide 62 reslizumab 62 Folotyn 62 R adalimumab 62 Mipomersen 62 Movectro 62 Soliris TM eculizumab 62 Entocort 62 rasagiline tablets 62 biologic therapy 62 CIP Fenofibrate 62 Degarelix 62 TREANDA 62 CAMPATH R 62 Resolor 62 Receives Orphan Drug 62 Nabi HB Intravenous 62 adult chronic ITP 62 PecFent 62 HuMax CD4 62 Glybera 62 KIACTA ™ 62 amrubicin 62 Eribulin 62 BEMA Fentanyl 62 Marketing Authorisation Application MAA 62 Ceplene histamine dihydrochloride 62 Vpriv 62 CIP TRAMADOL ER 62 severe hypercholesterolemia 62 Plicera 62 Maribavir 62 ONCASPAR 62 CLIA waiver 62 Naglazyme 62 Pixantrone 62 Emselex 62 idursulfase 62 Catena ® 62 cinacalcet HCl 62 Lodotra 62 MabCampath 62 Onsolis 62 Fibrillex TM 62 TORISEL TM 62 Gamunex C 62 Certolizumab pegol 62 Soliris eculizumab 62 OHR/AVR# 62 Everolimus 62 PNP inhibitor 62 BEXXAR 62 Epratuzumab 62 RAPTIVA 62 Zavesca r 62 Rhucin 62 NEUPREX R 62 Multiferon R 62 vemurafenib 62 Tetrabenazine 62 Troxatyl 62 Fabry Disease 62 liver resection surgeries 62 BENLYSTA 62 Decentralized Procedure 62 Voraxaze 62 Santhera 62 CIMZIA r 62 Clofarabine 62 sorafenib tablets 62 BioSTAR R 62 BLA submission 62 LUVENIQ 62 Orphan medicinal 62 ZADAXIN ® 62 commercialize oritavancin 62 Zarnestra 62 PDE4 inhibitor 62 TYZEKA 62 aerosolized AAT 62 Kynapid 62 Arzerra TM 62 Personalized Immunotherapy 62 Pegintron 62 Saforis 62 RhuDex R 62 FDA Accepts 62 novel oral anticoagulant 62 Pazopanib 62 acetonide FA 62 Loramyc ™ 62 European Medicines Evaluation 62 silodosin 62 Gleevec imatinib mesylate 62 Campath alemtuzumab 62 chronic idiopathic thrombocytopenic purpura 62 Serdolect ® 62 NOXAFIL 62 Bayer Nexavar 62 acyclovir Lauriad R 62 Fentanyl TAIFUN R 61 Belimumab 61 novel histone deacetylase 61 Golimumab 61 RANK Ligand inhibitor 61 Increlex TM 61 CytoFab 61 VIDAZA 61 Solasia 61 Viviant 61 IL# PE#QQR 61 Promacta 61 Orencia abatacept 61 diabetic neuropathic pain 61 MEZAVANT 61 desvenlafaxine 61 pseudobulbar affect PBA 61 Pemetrexed 61 fipamezole 61 Nuedexta 61 TroVax ® 61 drug ISA# 61 Ceplene ® histamine dihydrochloride 61 Bendamustine 61 QVAR 61 GEM #S 61 Eprodisate KIACTA TM 61 Vasovist 61 Zingo TM 61 Firdapse 61 Junovan TM 61 LUCASSIN 61 Treanda 61 Bronchitol 61 Lipsovir ® 61 Diamyd ® 61 Tracleer r 61 successfully commercialize Iluvien 61 refractory acute promyelocytic 61 Hexvix ® 61 IMA# 61 refractory chronic lymphocytic 61 ARIXTRA R 61 palifermin 61 Increlex ® 61 etanercept Enbrel 61 Kuvan R 61 Cinacalcet HCl 61 Modrenal R 61 Allovectin 7 ® 61 Approvable Letter 61 SUTENT 61 BioDelivery Sciences Announces 61 Reclast Aclasta 61 Grants Orphan Drug 61 ONSOLIS 61 lasofoxifene 61 Behcet uveitis 61 Urocidin 61 refractory APL 61 Alemtuzumab 61 MyVax R 61 heterozygous FH 61 mTOR inhibitor 61 Ozurdex 61 Cimzia 61 Ustekinumab 61 Simulect 61 targeted radiotherapeutic 61 omacetaxine mepesuccinate 61 Meets Primary Endpoint 61 Votrient 61 multiple myeloma MM 61 Expanded Indication 61 Relistor 61 granted Orphan Designation 61 Trovax 61 Receives Fast Track 61 Cancidas 61 Phenoptin 61 Severe VOD 61 Ceftobiprole 61 AZILECT ® 61 Firazyr ® 61 Actemra 61 Vectibix panitumumab 61 ONGLYZA ™ 61 Aclasta Reclast 61 RELISTOR ® 61 Velcade bortezomib 61 Temsirolimus 61 recurrent refractory 61 Phase III Clinical Trial 61 DC Bead 61 oral fludarabine 61 transfusional iron overload 61 Rescula 61 Zorbtive TM 61 Basilea Toctino R 61 registrational trial 61 Dacogen decitabine 61 STELARA TM 61 Onco TCS 61 Prestara 61 Biologic License Application BLA 61 Panzem 61 Neovastat 61 NEBIDO 61 SANVAR 61 TheraCIM 61 thalidomide Thalomid 61 VPRIV 61 cSSTI 61 Psoriasis Drug 61 Axentis Pharma 61 Cimzia certolizumab pegol 61 methylnaltrexone bromide 61 Erbitux cetuximab 61 Liprotamase 61 Rasagiline 61 rheumatoid arthritis psoriatic arthritis 61 ARCOXIA 61 pancreatic enzyme replacement 61 THALOMID R 61 Rituxan rituximab 61 Abiraterone acetate 61 Mycograb 61 investigational compound 61 rotigotine transdermal patch 61 XIAFLEX ™ 61 Eliquis 61 prGCD 61 phase IIb trial 61 ZEFTERA ™ 61 Uvidem 61 RhuDex 61 ADP receptor antagonist 61 Sylvie Gregoire President 61 PrevOnco ™ 61 ZOLINZA 61 Dr. McHutchison 60 Multaq R 60 Initiate Clinical Trial 60 tamibarotene 60 Traficet EN 60 USFDA approval 60 SCHWARZ PHARMA 60 R sorafenib tablets 60 Taxotere ® 60 approvable letters 60 Hexvix 60 RSR# 60 Teflaro 60 Maraviroc 60 RAPAFLO 60 Apricus Bio 60 Virulizin ® 60 Ceplene 60 R bendamustine hydrochloride 60 indolent NHL 60 immunotherapeutic vaccine 60 HuMax EGFr 60 Revlimid lenalidomide 60 apaziquone 60 DepoDur 60 RESOLOR 60 ixabepilone 60 YONDELIS R 60 Sensipar 60 IND Investigational New 60 Jevtana 60 Telzir 60 BYETTA ® 60 Clolar ® 60 Tasimelteon 60 Pivotal Phase III 60 Aurograb 60 ThermoDox ® 60 relapsing multiple sclerosis 60 Orexo 60 Somatuline Autogel 60 IPLEX 60 Mirapexin 60 human antithrombin 60 FOLOTYN ® 60 Voraxaze ™ 60 StemEx R 60 Replagal 60 chronic angina 60 induced macular edema 60 HQK 60 ENTEREG ® 60 antiplatelet agent 60 levocetirizine 60 tramiprosate ALZHEMED TM 60 IMiDs ® compound 60 Proxinium TM 60 Rasilez HCT 60 Yondelis 60 noninfectious uveitis 60 HepaGam B 60 vandetanib 60 SomatoKine 60 #D#C# 60 RhuDex ® 60 ezogabine 60 Plasmin 60 Ceflatonin ® 60 Expedited Review 60 HFA MDI 60 THELIN 60 VALSTAR 60 Rifaximin 60 FDA approvable letter 60 Insegia 60 Phase IIIb clinical 60 PD LID 60 HuMax TAC 60 Bafetinib 60 Valtropin 60 Eloxatin ® 60 Halaven 60 atacicept 60 amifampridine phosphate 60 ZALBIN 60 Cintredekin besudotox 60 generation purine nucleoside 60 cladribine 60 Lubiprostone 60 Zirgan 60 Preos 60 Morquio 60 JAK inhibitor 60 CHMP 60 Cloretazine ® 60 pediatric acute lymphoblastic 60 Iluvien ® 60 Ranexa R 60 Telatinib 60 Gaucher Disease 60 FOR FURTHER INFORMATION ABOUT 60 Joulferon 60 Teriparatide 60 Ruconest ™ 60 Azilect ® 60 Factor VIIa 60 Product Designation 60 Esbriet 60 Hsp# Inhibitor 60 CDP# 60 terlipressin 60 casopitant 60 LHRH antagonist 60 Diabetic Macular Edema 60 Vidaza azacitidine 60 AVASTIN 60 Bazedoxifene 60 AERx iDMS 60 sitaxsentan sodium 60 Kiacta 60 CIMZIA TM 60 REMINYL ® 60 Clolar 60 Kuvan 60 Cimzia ® 60 opioid induced constipation OIC 60 pain palliation 60 Swissmedic 60 TNF Tumor Necrosis Factor 60 tocilizumab 60 application sNDA 60 Adenuric ® 60 exocrine pancreatic insufficiency EPI 60 octreotide implant 60 Boceprevir 60 vapreotide acetate 60 Panzem R 60 voclosporin 60 Tasigna nilotinib 60 Celgene Revlimid 60 BLA filing 60 Ramelteon 60 PREOS R 60 Enzyme Replacement Therapy 60 Filgrastim 60 interferon gamma 1b 60 single injection viscosupplement 60 Serdolect 60 Roche Actemra 60 Microplasmin 60 CAPHOSOL 60 Vimpat ® lacosamide 60 BrachySil TM 60 Fingolimod 60 Synvisc One 60 OPAXIO 60 Humira adalimumab 60 Opterone R 60 IMiDs R 60 Marqibo TM 60 NerPharMa 60 Fortigel 60 oral FTY# 60 Azedra 60 anti inflammatory NSAID 60 REVLIMID lenalidomide 60 Invicorp R 60 Octreotide 60 PhotoCure 60 Ketotransdel 60 hereditary deficiency 60 Ixabepilone 60 Oxaliplatin 60 Vidaza 60 Aplidin 60 Frova ® 60 Spiegelmer ® 60 Flutiform TM 60 Phase IIb clinical trials 60 Granulocyte Colony Stimulating Factor 60 LEUKINE 60 proteasome inhibitor 60 Firdapse TM amifampridine phosphate 60 TRISENOX 60 Increlex 60 Ocrelizumab 60 Aloxi R 59 Lumacan 59 hypereosinophilic syndrome 59 PrevOnco 59 neovascular age 59 Clavis Pharma 59 TAXUS Element Stent System 59 ZEFTERA TM 59 Omalizumab 59 oral ridaforolimus 59 relapsing forms 59 Onbrez Breezhaler 59 MabThera 59 Rectogesic 59 Ambrisentan 59 Cefprozil 59 systemic immunosuppressive drugs 59 TYKERB 59 registrational studies 59 Glufast 59 Roflumilast 59 Allovectin 7 59 MORAb 59 Pixuvri 59 A1PI 59 Tanespimycin 59 mertansine 59 Decentralized Procedure DCP 59 lumiliximab 59 paliperidone palmitate 59 post operative ileus 59 BREAKYL 59 icatibant 59 Ilaris ® 59 Dapagliflozin 59 Vitaros 59 Photocure 59 Vidaza R 59 Pafuramidine 59 herpetic keratitis 59 GW# [003] 59 PREOS 59 Investigational Treatment 59 Elaprase 59 intravenous iclaprim 59 subsidiaries visit http:/www.apricusbio.com 59 THALOMID 59 InterfeRx 59 ADVEXIN 59 adalimumab Humira 59 sunitinib malate 59 anticancer compound 59 UCB Keppra 59 Manja Bouman CEO 59 Subpart E 59 HepaSphere 59 PEGylated anti 59 REVLIMID 59 Vimpat R 59 pancreatic insufficiency 59 Impavido R 59 vismodegib 59 Brinavess 59 Fortical R 59 HoFH 59 Exelon Patch 59 Invicorp 59 bazedoxifene 59 Prepandrix 59 PROVENGE sipuleucel T 59 Zavesca ® 59 BAL# [002] 59 Li Fraumeni Syndrome 59 Natalizumab 59 Cutaneous T 59 WILEX 59 Market Authorization Application 59 Thelin tm 59 Polyphenon ® E 59 Neupro R 59 Kamada AAT 59 Keppra ® XR 59 oral cladribine 59 investigational humanized monoclonal antibody 59 Vimpat 59 prasterone 59 Helsinn Healthcare 59 EGRIFTA TM 59 ATryn ® GTC recombinant 59 Amigal 59 Investigational Device Exemption 59 Eltrombopag 59 NOVARTIS 59 SIR Spheres 59 oral prodrug 59 Atryn 59 actinic keratosis 59 ATL# [001] 59 ITAX 59 AZILECT R 59 Tracleer R 59 Complete Response 59 ZEVALIN ® 59 OMAPRO 59 BCR ABL inhibitor 59 Cx# [002] 59 Velac 59 Sancuso 59 Marketing Authorizations 59 Clinical Trial Application 59 Martin Nicklasson CEO 59 ThermoDox R 59 Pivotal Study 59 Bosutinib 59 Keppra ® levetiracetam 59 AstraZeneca Iressa 59 Etravirine 59 SURFAXIN 59 TransMID TM 59 Gattex 59 NeoVisc ® 59 abiraterone acetate 59 pitavastatin 59 Renvela ® 59 Debiopharm SA 59 Gleevec imatinib 59 trabectedin 59 Tocilizumab 59 oxymorphone ER 59 MabThera rituximab 59 Fx #A 59 Orapred ODT 59 dual endothelin receptor antagonist 59 Rebif ® 59 Elesclomol 59 Nitec 59 CCR5 antagonist 59 Pertuzumab 59 Plenaxis TM 59 Juvantia 59 Recombinant Human 59 Fludara ® 59 Vfend 59 Synerx Pharma 59 Cetrorelix 59 CINQUIL 59 targeting CD# 59 Lovaza TM 59 Neupro 59 NeoVisc 59 MOVIPREP R 59 Xerese 59 AstraZeneca Symbicort 59 beta 1a 59 Horizant 59 Taxotere docetaxel 59 NDA Submission 59 Japanese Encephalitis Vaccine 59 BioDelivery Sciences 59 MGd 59 Aflibercept 59 Tramadol ER 59 REVLIMID ® 59 Arzerra 59 phase IIb clinical 59 G#DT 59 Herceptin trastuzumab 59 FOSRENOL 59 CE Marked 59 Daclizumab 59 Somatuline 59 REMICADE infliximab 59 opioid induced constipation 59 Evicel 59 Vitrasert R 59 Ofatumumab 59 Benlysta belimumab 59 pregabalin Lyrica 59 pulmonary arterial hypertension PAH 59 vidofludimus 59 Æterna Zentaris 59 IMiDs 59 injectable formulations 59 eprodisate Fibrillex TM 59 REBETOL combination 59 tapentadol 59 SmPC 59 Afatinib 59 cutaneous T 59 Prodarsan R 59 oral taxane 59 Biologics License Application 59 Pegloticase 59 Accelerated Assessment 59 BioAlliance 59 BENLYSTA ® 59 SAFLUTAN 59 IAP inhibitor 59 Zebinix 59 Restanza 59 Urokinase 59 SUMAVEL DosePro 59 acyclovir Lauriad ® 59 COPAXONE ® 59 Toctino R 59 sublingual tablets 59 supplemental biologics 59 Anavex #-# 59 recombinant interferon 59 regorafenib 59 Somatuline R Depot 59 Omapro 59 Dynepo 59 Fampyra 59 EGRIFTA ™ 59 REMICADE ® 59 receptor tyrosine kinase inhibitor 59 liposomal formulation 59 IMiDs ® 59 pediatric Crohn disease 59 Romidepsin 59 clobazam 59 tafamidis 59 Ganite ® 59 Luveniq 59 CE Marking 59 dirucotide MBP# 59 Cethromycin 59 MERREM 59 Extavia 59 Intravenous CP 59 basiliximab 59 ADVEXIN p# therapy 59 Gefitinib 59 VitiGam 58 QNEXA 58 antibody MAb 58 CRMD# 58 BEMA TM Fentanyl 58 Eligard R 58 REPLAGAL 58 Australian Therapeutic Goods 58 chronic ITP patients 58 Azacitidine 58 monoclonal anti 58 IRX 2 58 Dacogen TM 58 gepirone ER 58 diarrhea predominant irritable 58 Somatuline ® Autogel ® 58 Premarket Approval 58 Fresenius Biotech 58 aztreonam lysine 58 opioid induced bowel dysfunction 58 rhC1INH 58 AMEVIVE 58 AERIUS 58 Dyloject TM 58 alefacept 58 Rapydan 58 Pennsaid R 58 roflumilast 58 ISTODAX 58 Teijin Pharma 58 Arixtra 58 Virulizin 58 volociximab 58 Omacor ® 58 ONCONASE 58 Xanafide 58 GRALISE 58 Varespladib 58 refractory CLL 58 Zelnorm Zelmac 58 Initiates Enrollment 58 Xenazine ® 58 Zeneus 58 Multaq dronedarone 58 Mimpara R 58 psoriasis rheumatoid arthritis 58 TRX1 58 OLEPTRO 58 SNT-MC#/idebenone 58 IgG1 monoclonal antibody 58 Desmoteplase 58 Loramyc TM 58 Methylnaltrexone 58 Initiates Phase III 58 EOquin TM 58 OvaRex ® MAb 58 Collategene 58 ATL/TV# 58 cinacalcet 58 sBLA 58 ankylosing spondylitis psoriatic arthritis 58 non constipation irritable 58 maribavir 58 sNDA 58 Fanapt ™ 58 lymphoid malignancies 58 MGCD# [001] 58 Oncoscience AG 58 FlutiformTM 58 granted Orphan Drug 58 Ceflatonin R 58 Afinitor ® 58 ATG Fresenius S 58 OncoGel 58 Tacrolimus 58 Kineret R 58 Fablyn 58 Clinuvel 58 everolimus tablets 58 fibromyalgia syndrome 58 BioNumerik 58 Cerepro 58 ospemifene 58 FDA Complete Response 58 investigational therapies 58 Zemplar 58 Leukine ® 58 Potelligent Technology 58 recurrent herpes labialis 58 Amgen Prolia 58 Glivec imatinib 58 chimeric monoclonal antibody 58 Uracyst 58 prucalopride 58 Nippon Shinyaku 58 Levetiracetam 58 panitumumab Vectibix 58 mesylate 58 vernakalant hydrochloride 58 PROVENGE ® 58 PGL# 58 Congenital Emphysema 58 Solzira 58 Valdoxan

Back to home page